ABBOTT LABORATORIES (ABT)

US0028241000 - Common Stock

106.89  -0.7 (-0.65%)

Premarket: 106.77 -0.12 (-0.11%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ABBOTT LABORATORIES

NYSE:ABT (4/24/2024, 7:04:00 PM)

Premarket: 106.77 -0.12 (-0.11%)

106.89

-0.7 (-0.65%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap185.47B
Shares
PE24.07
Fwd PE23.03
Dividend Yield2.04%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABT Daily chart

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s portfolio of technologies spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Company Info

ABBOTT LABORATORIES

100 Abbott Park Rd

ABBOTT PARK ILLINOIS 60064

P: 12246676100

CEO: Robert B. Ford

Employees: 115000

Website: https://www.abbott.com/

ABT News

News Image2 days ago - InvestorPlaceDividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.

News Image3 days ago - InvestorPlace3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip

These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.

News Image6 days ago - Investor's Business DailyStock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review

The Nasdaq and S&P 500 tumbled below their 50-day lines.

News Image8 days ago - Market News VideoWednesday Sector Laggards: Healthcare, Technology & Communications
News Image8 days ago - Market News VideoNoteworthy Wednesday Option Activity: LULU, ABT, AIG
News Image8 days ago - The Motley FoolAbbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

ABT earnings call for the period ending March 31, 2024.

ABT Twits

Here you can normally see the latest stock twits on ABT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example